InMed Pharmaceuticals SEC Filings
NASDAQ: INMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.36+0.03 (+2.26%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InMed Pharmaceuticals filing overview
This page lists 1 recent SEC filings by InMed Pharmaceuticals (INM), including 1 4. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
INM SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 8, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |